Hennessy Capital Investment Corp. VII

NASDAQ:HVII

Financial - Conglomerates

Financial Services
$4.46 -0.05%

-$0.01 today

Market cap
$116.06M
Beta
0.05
P/E (TTM)
61.2
EPS (TTM)
$0.17
52W Low $10.13High $10.99

Volume 10.51M

Average 0.05M

HVII Cash & Equivalents

Cash on hand and highly liquid investments that can be converted to cash almost immediately.

Hennessy Capital Investment Corp. VIINASDAQ: HVII

Cash & Equivalents · Q1 FY2026 · quarter ended Mar 2026

Cash & equivalents falls 84.2% from a year ago

Cash & equivalents stood at $323.22K at the end of Q1 FY2026, down 84.2% from a year earlier and down 67.2% from the prior quarter.

Context

  • Cash & equivalents amounted to 0.2% of total assets at the end of Q1 FY2026, down 0.9 pp from a year earlier.

What to watch

Whether cash & equivalents keeps falling in the next quarterly balance sheet after a -84.2% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$323.22K-67.2% QoQ
Last fiscal yearDec 2025
$984.25K+4820.0% YoY
Year agoMar 2025
$2.04M-84.2% since
Cash & Equivalents past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-84.2%——
1 year+4820.0%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Cash & Equivalents history

USD · from the balance sheet

Latest · FY2025
984.25K USD
Year-over-year change
+4820.0%
1-year CAGR
+4820.0%

Cash & Equivalents vs competitors

How HVII compares with its peers on the latest reported figures

  • HVII's Mar 2026 cash & equivalents of $323.22K is the 5th highest of the 11 companies compared; the peer median is $122.01K.
  • Its year-over-year change of -84.2% is the 8th highest of 10, against a peer median of -66.2%.
  • Cash & equivalents amounts to 0.2% of total assets for HVII, versus a peer median of 0.1%.
HVII Competitors Peer median
Cash & Equivalents for HVII and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
OACCOaktree Acquisition Corp. III Life SciencesMar 2026$1.28M -0.4%—0.6%
AACIArmada Acquisition Corp. IIIMar 2026$903.35K ——0.4%
BEAGBold Eagle Acquisition Corp.Mar 2026$521.35K +3295.5%—0.2%
FACTFACT II Acquisition CorpMar 2026$412.91K -66.2%+95.5%0.2%
HVIIHennessy Capital Investment Corp. VIIMar 2026$323.22K -84.2%—0.2%
POLEAndretti Acquisition Corp. IIMar 2026$150.52K -75.4%—0.1%
PLMKPlum Acquisition Corp. IVMar 2026$93.51K -83.8%—0.1%
SOULSoulpower Acquisition Corp.Mar 2026$56.4K +1616.5%—0.0%
DRDBRoman DBDR Acquisition Corp. IIMar 2026$53.49K -94.4%—0.0%
AACBArtius II Acquisition Inc. Class A Ordinary SharesMar 2026$20.3K -94.3%—0.0%
DMAADrugs Made In America Acquisition Corp. Ordinary SharesMar 2026$14.89K +1512.9%—0.0%
Peer median (excluding HVII) $122.01K-66.2%+95.5%0.1%

Competitors are the stored peer set for HVII. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Hennessy Capital Investment Corp. VII

NASDAQ:HVII

Intrinsic Alpha fair value

Locked

Current Price

$4.46

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.